FERRETTI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 17.591
AS - Asia 8.476
EU - Europa 6.328
SA - Sud America 1.800
AF - Africa 164
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 34.388
Nazione #
US - Stati Uniti d'America 17.282
SG - Singapore 3.506
IT - Italia 2.249
CN - Cina 2.209
BR - Brasile 1.506
HK - Hong Kong 945
UA - Ucraina 935
DE - Germania 933
TR - Turchia 688
VN - Vietnam 466
GB - Regno Unito 455
RU - Federazione Russa 341
SE - Svezia 305
PL - Polonia 287
FI - Finlandia 259
ID - Indonesia 165
MX - Messico 143
FR - Francia 131
CA - Canada 129
AR - Argentina 115
NL - Olanda 109
IN - India 99
AT - Austria 66
BD - Bangladesh 64
ZA - Sudafrica 64
ES - Italia 57
JP - Giappone 52
EC - Ecuador 48
IQ - Iraq 43
BE - Belgio 38
PK - Pakistan 37
VE - Venezuela 32
CO - Colombia 28
IR - Iran 26
PY - Paraguay 26
CZ - Repubblica Ceca 22
UZ - Uzbekistan 21
CH - Svizzera 19
CL - Cile 19
AU - Australia 18
KE - Kenya 18
LT - Lituania 18
MA - Marocco 18
JO - Giordania 17
MY - Malesia 15
EG - Egitto 12
KZ - Kazakistan 12
NP - Nepal 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
IE - Irlanda 11
PE - Perù 11
KR - Corea 10
RO - Romania 10
TN - Tunisia 10
AZ - Azerbaigian 9
EU - Europa 9
RS - Serbia 9
SA - Arabia Saudita 9
BO - Bolivia 8
IL - Israele 8
SM - San Marino 8
SN - Senegal 8
DO - Repubblica Dominicana 7
TW - Taiwan 7
CR - Costa Rica 6
DK - Danimarca 6
DZ - Algeria 6
HN - Honduras 6
LB - Libano 6
LV - Lettonia 6
OM - Oman 6
PT - Portogallo 6
UY - Uruguay 6
BG - Bulgaria 5
HU - Ungheria 5
JM - Giamaica 5
TH - Thailandia 5
AO - Angola 4
CY - Cipro 4
EE - Estonia 4
GH - Ghana 4
HR - Croazia 4
PH - Filippine 4
SI - Slovenia 4
AM - Armenia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
GE - Georgia 3
GT - Guatemala 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
Totale 34.359
Città #
Fairfield 2.120
Woodbridge 1.928
Singapore 1.913
Ashburn 1.537
Jacksonville 1.116
Houston 1.075
Chandler 945
Hong Kong 939
Seattle 849
Santa Clara 737
Wilmington 725
Cambridge 718
Ann Arbor 696
Beijing 606
Izmir 460
Nanjing 366
Princeton 283
Warsaw 277
Dallas 256
Dearborn 237
Ferrara 213
Milan 203
Ho Chi Minh City 184
Los Angeles 181
San Diego 172
Bremen 162
New York 158
Boardman 137
Rome 133
Munich 125
São Paulo 122
Jakarta 120
Nanchang 105
Mexico City 92
Hanoi 86
Hebei 82
Tianjin 82
Hefei 79
Moscow 76
Falls Church 74
Shenyang 72
Bologna 70
Shanghai 70
Nuremberg 65
London 59
Chicago 55
Changsha 53
Jiaxing 51
Rio de Janeiro 50
Redwood City 48
Mountain View 47
Kunming 46
Buffalo 45
Naples 45
San Jose 44
The Dalles 44
Belo Horizonte 41
Tokyo 41
Orange 40
Council Bluffs 39
Jinan 39
Turku 39
Brooklyn 37
Montreal 37
Columbus 36
Norwalk 36
Vienna 36
Stockholm 35
Brussels 34
Johannesburg 34
Florence 33
Brasília 32
San Francisco 32
Toronto 32
Helsinki 31
Atlanta 30
Curitiba 30
Guangzhou 30
Zhengzhou 29
Turin 27
Amsterdam 26
Frankfurt am Main 25
Haiphong 25
Palermo 25
Boston 24
Orem 24
Chennai 22
Guayaquil 22
Lappeenranta 22
Ningbo 22
Porto Alegre 22
San Mateo 22
St Petersburg 22
Falkenstein 21
Ankara 20
Manchester 20
Verona 20
Denver 19
Guarulhos 19
Phoenix 19
Totale 22.504
Nome #
Mixed odontogenic tumors. Studies on the significance of correlations between ameloblastic fibroma, ameloblastic fibro-odontoma and odontoma 531
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 489
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 388
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 296
Survival of cancer patients in Europe: the EUROCARE study 266
I tumori in Emilia-Romagna 256
I tumori in Italia, rapporto 2007: sopravvivenza. 250
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 224
Characteristics of the colorectal cancers diagnosed in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening [Caratteristiche dei tumori del colon retto diagnosticati in Italia nei primi anni Duemila. Dati dello studio IMPATTO sdelo screening colorettale] 222
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 220
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 216
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 211
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 198
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 189
Application of quantitative analysis to biologic profile evaluation in breast cancer 185
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 183
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 182
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 181
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 177
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 176
Axyllary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patiensts 174
The effect of palliative care on the assistance of terminally ill cancer patients in the Province of Ferrara in 2002 173
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 173
I programmi di screening oncologici in Emilia-Romagna. I dati dei seminari regionali 2016 171
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 171
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 170
Completeness and timeliness: Cancer registries could/should improve their performance 169
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 168
The burden of HPV-related diseases in Italy, 2001-12 168
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 168
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 168
An estimate of the number of people in Italy living after a childhood cancer 167
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 166
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 165
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 164
Registro Tumori della provincia di Ferrara 163
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 162
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 162
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 161
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 160
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 160
Epidemiology of rare cancers and inequalities in oncologic outcomes 160
Survival from salivary glands adenoid cystic carcinoma in European populations 160
Il protocollo Diagnostico-Terapeutico e Assistenziale per il carcinoma mammario della Regione Emilia-Romagna. I edizione 160
Italy, Ferrara province 155
Contribution of cell kinetics with Ki-67 to the biopathological and prognostic characterization of breast cancer 155
International incidence of childhood cancer, 2001-10: a population-based registry study 155
Quantitative immunoprofiles of breast cancer performed by image analysis 154
Il problema dei tumori in provincia di Ferrara: incidenza, mortalità e prospettive terapeutiche 151
p53 Expression in colorectal cancer: Relation to tumor type, DNA ploidy pattern, and short-term survival 151
Modulation of biomarkers in minimal breast carcinoma: A model for human breast carcinoma progression 150
Treatment challenges in and outside a network setting: Soft tissue sarcomas 150
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy 149
The Results of an Italian Quality Assurance Program Support the New American Society for Colposcopy and Cervical Pathology Recommendations for Colposcopy Practice 149
BRCA1 LOH and biological profile of breast cancer. Comparison between two age groups. 149
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 148
Estimates of cancer burden in Emilia-Romagna 148
Classificazione TNM dei tumori maligni, VII edizione 2009. Novità e ricadute pratiche per l’epidemiologia dei tumori. 148
Biological profile of breast carcinoma in situ investigated by immunohistochemical technique 147
Early (short-interval) rescreen in mammography screening 146
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 146
Cancer prevalence estimates in Europe at the beginning of 2000 145
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 144
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 144
Indicatori e valori di riferimento nella valutazione della ploidia del carcinoma mammario 142
I tumori in Italia - Rapporto 2012. I tumori dei bambini e degli adolescenti [Italian cancer figures, report 2012: Cancer in children and adolescents] 142
[The contribution of the Italian association of cancer registries (AIRTUM)] 141
Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening 141
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 140
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 140
The burden of rare cancers in Europe 140
National estimates of cancer patients survival in italy: A model-based method 139
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 139
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 139
Screening history of cervical cancers in Emilia-Romagna, Italy: defining priorities to improve cervical cancer screening 138
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 138
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 138
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 137
Regional inequalities in cancer care persist in Italy and can influence survival 137
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 137
Incidence, survival and prevalence of myeloid malignancies in Europe 136
Survival of European patients with central nervous system tumors 136
Rare cancers of the head and neck area in Europe 136
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 136
Estimates of cancer burden in Italy 135
Rare cancers are not so rare: the rare cancer burden in Europe 135
Cancer Incidence in Ferrara Province (1998-2002) 135
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 135
AIRTUM e SIE insieme per una definizione condivisa dei tumori emolinfopoietici [AIRTUM and SIE for a shared definition of haemolymphopoietic cancers] 135
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 135
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 135
Cancer incidence and mortality trends from 2003 to 2014 in Italy 135
Aggiornamento della sopravvivenza dei pazienti con tumore in Italia: confronti geografici e focus su pazienti con tumori oggetto di screening, pediatrici e associati al fumo [Update of survival of cancer patients in Italy: geographical comparisons and focus on patients with cancers targeted by screening programmes, childhood cancers, and smoking-associated cancers] 134
Incidence and survival of rare urogenital cancers in Europe 134
Changes in cervical cancer incidence following the introduction of organized screening in Italy 134
The cure of cancer: A European perspective 134
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 134
Breast screening: axillary lymph node status of interval cancers by interval year 133
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 133
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 132
Totale 16.927
Categoria #
all - tutte 172.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.110
Totale 178.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.076 0 0 0 0 0 313 155 415 179 410 366 238
2021/20222.548 87 295 205 166 129 144 134 195 109 203 188 693
2022/20232.580 312 127 52 266 488 379 61 253 328 34 170 110
2023/20241.426 170 169 60 75 99 125 61 74 44 67 90 392
2024/20255.931 208 147 527 191 728 427 366 401 889 777 686 584
2025/20267.695 1.230 661 1.483 1.800 1.860 661 0 0 0 0 0 0
Totale 34.917